18983288589(微信同号)
18983288589(微信同号)
18908392210(微信同号)
18980413049
ChiCTR-IPC-15007294
结束
/
/
/
2015-10-28
/
/
stroke, aphasia
應用雙側經顱磁刺激對中風後失語症康復的研究:從亞急性期到慢性期
應用雙側經顱磁刺激對中風後失語症康復的研究:從亞急性期到慢性期
應用雙側經顱磁刺激對中風後失語症康復的研究:從亞急性期到慢性期
非随机对照试验
其它
NA
/
Nil
/
10
/
1990-01-01
1990-01-01
/
1. aged 18 or above, right-handed, Cantonese native speaker; 2. first-ever ischemic stroke with onset time less than 21 days and left middle cerebral artery (LMCA) territory involved; 3. recordable motor evoked potential (MEP) in either hand; 4. mild to moderate motor-dominant aphasia (National Institution of Health Stroke Scale (NIHSS) Part 9 = 1); 5. capable of undergoing language assessment (NIHSS Part 1a=0, 1b=0 or 1 and 1c= 0 or 1); 6. the patient or his/her legally acceptable representative is willing to provide written informed consent.;
登录查看1. personal history of epilepsy; 2. metallic implants in any part of body; 3. implanted cardiac pacemaker, defibrillator, medication pump or any other implanted electronics; 4. severe skull fracture, serious head injury, history of brain or spinal cord surgery; 5. brain tumor on CT/MRI; 6. administration of drugs that potentially lower seizure threshold; 7. active malignancy; 8. severe co-existing systemic diseases, severe dementia or psychosis; 9. inability to be followed up at regular interval; 10. pregnancy or breast-feeding; 11. pure word deafness; 12. diagnosed dementia; 13. clinical evidence of depression; 14. clinical sign of hearing or visual impairment without aids; 15. alcohol abuse and drug addiction.;
登录查看Division of Neurology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong
/
约印创投2025-01-16
求实药社2025-01-16
Genhouse2025-01-16
IPHASE2025-01-16
动脉网2025-01-16
动脉网-最新2025-01-16
药明康德2025-01-16
药明康德2025-01-16
再鼎医药2025-01-16
Rimonci2025-01-15